Xometry director Altschuler reports $1.09M class A common stock sale

Xometry director Randolph Altschuler reported selling 10,000 shares for approximately $1.09 million on November 5, 2026, under a spouse-adopted Rule 10b5-1 plan; shares traded at $114.95, near a $117.50 52-week high. The article also cites a 76% one-year share gain and an InvestingPro assessment that the stock appears overvalued. Separately, Xometry reported Q3 adjusted EPS of $0.28 and revenue of $252.4 million, up 40% year over year, while Cantor Fitzgerald, Wedbush and Citizens raised their price targets to $114, $140 and $135, respectively.

Analysis

The planned sale is weak evidence of deteriorating insider conviction: a spouse-adopted Rule 10b5-1 plan predating the trade substantially limits its value as a discretionary timing signal. The more important setup is whether recent operating leverage is repeatable. Higher Marketplace gross margin can support a durable earnings re-rating if it reflects better take rates, sourcing efficiency, or mix; if it instead reflects temporary order mix or unusually favorable demand, the sharp rerating leaves XMTR vulnerable to estimate compression. A strong quarter and raised guidance improve the near-term fundamental case, but analyst target increases after results are not independent proof that the new earnings trajectory is sustainable.

Over days, price action near the 52-week high may amplify volatility and profit-taking; the insider transaction alone does not justify a short. Over 1–3 months, watch order growth, repeat customer activity, Marketplace gross margin, and conversion of gross profit into cash flow. Over 6–18 months, the key question is whether Xometry’s marketplace model compounds share gains against alternatives such as Protolabs, or whether industrial demand cyclicality and competitors’ pricing limit margins. The contrarian risk to bears is that a platform with improving unit economics could warrant a higher multiple than conventional manufacturing peers. The risk to bulls is that a high bar makes merely good results insufficient.

Key Decisions for Investors

• Do not treat this 10b5-1 sale as a standalone short signal. For existing XMTR longs, consider trimming into strength or using a collar rather than exiting solely on the filing.
• Avoid chasing at current levels until the next operating update confirms Marketplace gross-margin durability and cash conversion. Verify order growth, repeat-customer trends, and any change in full-year guidance.
• A tactical bearish setup is conditional, not immediate: consider a defined-risk put spread only if XMTR fails to hold near its stated 52-week high and subsequent guidance or margin metrics weaken. The thesis is falsified by sustained trading above that high alongside stable or improving margins and guidance.
• Monitor Protolabs as a competitive read-through, but do not assume direct comparability: assess relative growth, gross-margin trends, and customer/order disclosures before constructing a pair trade.